From: A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis
Sample | Mean (SD) | P value | |
---|---|---|---|
DNA | Case | 155.50 (118.68) | 0.02 |
Control | 210.10 (97.25) | ||
Total bacteria | Case | 10.36 (0.86) | 0.90 |
Control | 10.34 (0.74) | ||
Lactobacillus spp. | Case | 5.44 (1.26) | 0.09 |
Control | 5.77 (0.76) | ||
Bifidobacterium spp. | Case | 7.30 (1.63) | 0.54 |
Control | 7.43 (1.28) | ||
E. coli | Case | 6.60 (1.13) | 0.04 |
Control | 6.0 (1.61) | ||
Clostridium cluster I | Case | 5.72 (1.55) | 0.01 |
Control | 6.39 (0.84) | ||
Enterobacteriaceae | Case | 8.51 (0.8) | 0.05 |
Control | 7.96 (1.84) | ||
Total yeast | Case | 5.78 (0.81) | 0.02 |
Control | 6.07 (0.65) |